The University of Sussex in the UK has selected Mace Group as its construction partner for the new Life Sciences facility.
A part of a £500m modernisation programme, the new facility will be built within the university’s Falmer campus near Brighton.
Mace’s public sector and education construction business unit Preach will be responsible for delivering the project.
University of Sussex director of estates and facilities Simon Neale said: “Mace has clearly understood our ambition to develop a beacon of science and innovation excellence that will bring significant economic and social benefit to the South East and the UK.
“We will work together to create outstanding modern laboratories and high-tech teaching and research spaces that will inspire the scientists of tomorrow and our talented group of world-leading academics.”
Hawkins Brown Architects has designed the new building, which will include the use of glass, concrete, brick and green spaces.
Set over five floors and covering more than 17,000m², the new facility will include green roofs, open courtyard spaces, an internal street, collaborative spaces for staff and students and modern laboratories.
The building will also feature a Bio-Innovation Centre for bio-medical businesses, which will strengthen the university’s partnerships with industry and create more jobs in the region. Around £5.5m from the UK Government’s Growth Fund has been granted in funding for the centre.
Construction work on the new facility is set to begin next year.
Mace is a global consultancy and construction firm headquartered in London and operating in 21 sectors from five global hubs.
Mace’s Preach business unit director Terry Spraggett said: “We’re obviously very pleased that the University of Sussex has selected us to deliver their new Life Sciences facility, which will provide enhanced teaching and research facilities for students and academics.
“We are experienced in delivering world-class research facilities for institutions across the UK, and it’s always a privilege to be given the opportunity to work on projects that have such potential to transform our understanding of biomedical science.”